Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria. Balwani M, Sardh E, Ventura P, Peiro PA, et al. N Engl J Med 2020;382:2289-2301.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Balwani M, Sardh E, Ventura P, Peiro PA, et al. Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria. N Engl J Med 2020;382:2289-2301.
PMID: 32521132